Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2025-12-25 @ 9:16 PM
Study NCT ID:
NCT01510756
Status:
TERMINATED
Last Update Posted:
2016-01-21
First Post:
2012-01-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Sponsor:
Thomas Kipps
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-11
First Submit QC Date:
None
Study First Post Date:
2012-01-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-08-21
Results First Submit QC Date:
None
Results First Post Date:
2015-10-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-16
Last Update Post Date:
2016-01-21
Last Update Post Date Type:
ESTIMATED